CCND1 and ovarian carcinoma: A recent study has identified that MYC, EGFR, and CCND1 can be amplified on extrachromosomal DNA (ecDNA) in different tumor cell lines [33], which may provide novel insight into identification of the mechanism of ovarian cancer progression.